TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05054166 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT06298344 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT06298344 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT06442449 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04678479 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT00005779 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00005779 — Safety Biomarker (SAF): Interleukin 12
Study NCT06530082 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05105477 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05368233 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT05382936 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05196711 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study NCT05725759 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05637255 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05084534 — Surrogate Endpoint (SUR): Serum sodium
Study NCT06086015 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05677672 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT06572618 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05945862 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05402384 — Predictive Biomarker (PRD): SLC35A2 mRNA
Genes: SLC35A2; UGALT; UGT; UGTL
Study NCT06334367 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT06720597 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT05448625 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT05457582 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03984383 — Predictive Biomarker (PRD): IL33 mRNA
Genes: IL33; C9orf26; IL1F11; NFHEV
Study NCT05002920 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05154370 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT06220695 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT06221527 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05772351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05841381 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04198350 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06318884 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05345522 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04230499 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05407740 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT05733455 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05733455 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05649631 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05649631 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05061485 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT05061485 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT05888207 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT05755633 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT00751894 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05071898 — Predictive Biomarker (PRD): GLP1R mRNA
Genes: GLP1R
Study NCT06163677 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05878028 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05300048 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05300048 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05300048 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05103059 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05015985 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06292897 — Predictive Biomarker (PRD): LDHA mRNA
Genes: LDHA; PIG19
Study NCT06292897 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT06153147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05302284 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05234450 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05234450 — Predictive Biomarker (PRD): DAXX mRNA
Genes: DAXX; BING2; DAP6
Study NCT05234450 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study NCT05234450 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05234450 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06027801 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04052139 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04904783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04904783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05035485 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05381350 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05354726 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05477407 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT05549258 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT04736823 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04736823 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05669742 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05669742 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06130709 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05814419 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04603898 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT04739839 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT04976452 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05461573 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04860908 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06398743 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06452433 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06452433 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05498428 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04441073 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05224596 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05224596 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05232734 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06656611 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06555796 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05329727 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05692752 — Predictive Biomarker (PRD): MYH7 mRNA
Genes: MYH7; MYHCB
Study NCT05692752 — Safety Biomarker (SAF): miR-133a
Study NCT06514534 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT06131528 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000750 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05064865 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05438966 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04782791 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00000979 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06246383 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06328738 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05430347 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05430347 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05584709 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05613075 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04457089 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05722925 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05722925 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT06351293 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06169215 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05250856 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT06389877 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT05588609 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study NCT06468358 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04634552 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06409936 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT06409936 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05652426 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT04774003 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04774003 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06168071 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05292898 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05292898 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05009433 — Predictive Biomarker (PRD): SLC26A3 mRNA
Genes: SLC26A3; DRA
Study NCT05009433 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06237881 — Predictive Biomarker (PRD): SOCS1 mRNA
Genes: SOCS1; SSI1; TIP3
Study NCT05022849 — Predictive Biomarker (PRD): KLK2 mRNA
Genes: KLK2
Study NCT04842032 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT05566483 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05879510 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT06538324 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00203684 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT06282588 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00002165 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05186753 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT06526858 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04939857 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT04939857 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05559164 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06208150 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05386914 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04739371 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05111314 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05167825 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04916860 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05686070 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05532696 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04562441 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04748029 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05641688 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05099978 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05364684 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT05087030 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05005884 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT05653531 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT06120140 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06120140 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06150157 — Predictive Biomarker (PRD): CALR mRNA
Genes: CALR; CRTC
Study NCT04848493 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06040242 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06035939 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06656065 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT06656065 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT05958173 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT05958173 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT06100432 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT05477628 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06500741 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT05222139 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00002285 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05379569 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05233046 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06444711 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06090318 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT06090318 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05076149 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05076149 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT05117086 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05118737 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06370078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06509490 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05680805 — Predictive Biomarker (PRD): SLC22A1 mRNA
Genes: SLC22A1; OCT1
Study NCT06489288 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT04881838 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04930744 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05599516 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05538156 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT04631718 — Predictive Biomarker (PRD): Liver iron
Study NCT05904886 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT05499156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05499156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05444530 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study NCT05457283 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05457283 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05457283 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05457283 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04916886 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04888611 — Predictive Biomarker (PRD): GSC mRNA
Genes: GSC
Study NCT05224011 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05412706 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05278390 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06454864 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study NCT06063564 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06401980 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05230147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05383014 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05383014 — Predictive Biomarker (PRD): FLT3
Genes: STK1; FLK2; CD135
Study NCT06274125 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05128539 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05153343 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05153343 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05153343 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study NCT04894994 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06379451 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05676710 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04661254 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04661254 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT05240261 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06246149 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04982393 — Predictive Biomarker (PRD): PHC1 mRNA
Genes: PHC1; EDR1; PH1
Study NCT06453057 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06096298 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06529068 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06195150 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT04965519 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06335888 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT06656728 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study NCT06657287 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06296394 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05928806 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT05928806 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05789680 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT05834777 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05177796 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05984745 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05469022 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05469022 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05889260 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT05650879 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05983237 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06080165 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04655482 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04813614 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05526885 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05909397 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05909397 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05527119 — Predictive Biomarker (PRD): ACKR1 mRNA
Genes: ACKR1; DARC; FY; GPD
Study NCT05998733 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04998201 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study NCT05605028 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06093971 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT06093971 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05519020 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04904432 — Predictive Biomarker (PRD): PLIN1 mRNA
Genes: PLIN1; PERI; PLIN
Study NCT05418335 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05738915 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04653584 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04653584 — Safety Biomarker (SAF): DRD2
Study NCT04840030 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04840030 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06463275 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT05438290 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05935423 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06080581 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT06142890 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05675683 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06155383 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06362759 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06158139 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT05891964 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04879329 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05356728 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05474560 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05921929 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF